Gipper: Isn't it common knowledge that BD is the one who has been performing our Analytical Performance Testing? Gerald said in his blog this week that BD had successfully passed off testing to our "Target Partner" several times in the past. (Which makes me think the partner is Quest.)
Remember back in November of 2013 when we were all waiting for the BD Validation of LymPro? They did our testing in 2013 and have been doing our testing this year for CLIA certification.
When AD experts in Copenhagen receive Gerald's incredible data, the first thing they will think is, "Oh sure, this upstart says his test can be 90% plus accurate, but how reliable was the testing?" That is what will go through the minds of every AD expert. Then when they read that Becton Dickinson did the testing, one of the most prominent diagnostic companies in the world, they will be stunned!!! They will be forced to take notice!!
This isn't me making this stuff up. I don't know anything. This has been Gerald's plan all along, to get the credibility of BD behind LymPro's testing so we could sway KOLs (Key-Opinion-Leaders) around the AD community to accept LymPro as the NEW INDUSTRY STANDARD for early onset AD detection.
Remember back in November of 2013 when we were all waiting for the BD Validation of LymPro? They did our testing in 2013 and have been doing our testing this year for CLIA certification.
When AD experts in Copenhagen receive Gerald's incredible data, the first thing they will think is, "Oh sure, this upstart says his test can be 90% plus accurate, but how reliable was the testing?" That is what will go through the minds of every AD expert. Then when they read that Becton Dickinson did the testing, one of the most prominent diagnostic companies in the world, they will be stunned!!! They will be forced to take notice!!
This isn't me making this stuff up. I don't know anything. This has been Gerald's plan all along, to get the credibility of BD behind LymPro's testing so we could sway KOLs (Key-Opinion-Leaders) around the AD community to accept LymPro as the NEW INDUSTRY STANDARD for early onset AD detection.
